Recruiting PHASE4 Spondyloarthritis (SpA)

Tests treatment safety and results for Spondyloarthritis (SpA)

Official title Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis

ClinicalTrials.gov ID: NCT06707194

What this study is testing

What is Etanercept?

Etanercept is an investigational medicine, given as an injection into a muscle, being studied as a potential treatment for spondyloarthritis (spa).

Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
The purpose of the study is to verify the clinical feasibility of Benzathine penicillin (BPG) /Etanercept (ETN) combination regimen in patients with spondyloarthritis (SpA) and at the same time compare Benzathine penicillin /Etanercept combination regimen and Etanercept maintenance therapy in reducing disease activity, improving patients' clinical symptoms and body function scores, enhancing quality of life, improving imaging performance and safety.
  • Phase 4: studies an already-approved treatment
  • You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 59

You may be able to join if

  • The following patients would be included: (1) The people voluntarily participate and sign an informed consent form; (2) patients aged 18-59 years...

You likely can't join if

  • he exclusion criteria are as follows: (1) people with nasopharyngitis, active tuberculosis, inflammatory bowel disease and other infections, other...

The study team makes the final eligibility decision.

Where it's taking place

  • Hefei, Anhui, China
  • Chongqing, Chongqing Municipality, China
  • Guangzhou, Guangdong, China
  • Hohhot, Inner Mongolia, China
  • Ganzhou, Jiangxi, China

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 59 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Hefei, Anhui, China; Chongqing, Chongqing Municipality, China; Guangzhou, Guangdong, China; Hohhot, Inner Mongolia, China; Ganzhou, Jiangxi, China. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.